Th17 cells, pathogenic or not? TGF-β3 imposes the embargo.
作者信息
Sharma Meenu, Kaveri Srini V, Bayry Jagadeesh
机构信息
Unité 872, Institut National de la Santé et de la Recherche Médicale, Paris, France.
出版信息
Cell Mol Immunol. 2013 Mar;10(2):101-2. doi: 10.1038/cmi.2012.72. Epub 2013 Feb 11.
Abstract
摘要
相似文献
1
Th17 cells, pathogenic or not? TGF-β3 imposes the embargo.
Cell Mol Immunol. 2013 Mar;10(2):101-2. doi: 10.1038/cmi.2012.72. Epub 2013 Feb 11.
2
Induction and molecular signature of pathogenic TH17 cells.
Nat Immunol. 2012 Oct;13(10):991-9. doi: 10.1038/ni.2416. Epub 2012 Sep 9.
3
Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity.
J Clin Invest. 2015 Jun;125(6):2211-9. doi: 10.1172/JCI78085. Epub 2015 May 11.
4
[Regulation of antigen specific Th17 cells differentiation in experimental autoimmune uveitis].
Zhonghua Yan Ke Za Zhi. 2012 Mar;48(3):234-40.
5
Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
Am J Pathol. 2012 Jul;181(1):8-18. doi: 10.1016/j.ajpath.2012.03.044. Epub 2012 May 26.
6
IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease.
Eur J Immunol. 2011 Apr;41(4):952-62. doi: 10.1002/eji.201040879. Epub 2011 Feb 24.
7
Regulation of T helper cell subsets by cyclooxygenases and their metabolites.
Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:74-83. doi: 10.1016/j.prostaglandins.2012.11.002. Epub 2012 Nov 28.
8
Immunosuppressive exosomes from TGF-β1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells.
Cell Res. 2012 Mar;22(3):607-10. doi: 10.1038/cr.2011.196. Epub 2011 Dec 13.
9
Analysis of TGF-β1 and TGF-β3 as regulators of encephalitogenic Th17 cells: Implications for multiple sclerosis.
Brain Behav Immun. 2015 May;46:44-9. doi: 10.1016/j.bbi.2014.12.007. Epub 2014 Dec 10.
10
IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells.
J Immunol. 2014 Oct 1;193(7):3322-31. doi: 10.4049/jimmunol.1400775. Epub 2014 Aug 29.
引用本文的文献
1
TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy.
Cancer Immunol Immunother. 2025 Jul 12;74(8):268. doi: 10.1007/s00262-025-04103-2.
2
Higher Synovial Immunohistochemistry Reactivity of IL-17A, Dkk1, and TGF-β1 in Patients with Early Psoriatic Arthritis and Rheumatoid Arthritis Could Predict the Use of Biologics.
Biomedicines. 2024 Apr 8;12(4):815. doi: 10.3390/biomedicines12040815.
3
Novel Probiotic Bacterium subsp. (Canan SV-53) Modulates Gut Immunity through Epigenetic Mechanisms.
Microorganisms. 2023 Sep 29;11(10):2456. doi: 10.3390/microorganisms11102456.
4
Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis.
BMC Musculoskelet Disord. 2023 Mar 30;24(1):246. doi: 10.1186/s12891-023-06339-4.
5
Effect of IL-10 Deficiency on TGFβ Expression during Fatal Alphavirus Encephalomyelitis in C57Bl/6 Mice.
Viruses. 2022 Aug 16;14(8):1791. doi: 10.3390/v14081791.
6
The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming.
Cell Metab. 2022 Apr 5;34(4):516-532.e11. doi: 10.1016/j.cmet.2022.02.015. Epub 2022 Mar 21.
7
Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.
Dig Dis Sci. 2022 Apr;67(4):1163-1186. doi: 10.1007/s10620-021-06968-6. Epub 2021 Apr 9.
8
Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.
Cancer Immunol Immunother. 2021 Aug;70(8):2339-2351. doi: 10.1007/s00262-021-02867-x. Epub 2021 Jan 29.
9
The Many Faces of CD4 T Cells: Immunological and Structural Characteristics.
Int J Mol Sci. 2020 Dec 23;22(1):73. doi: 10.3390/ijms22010073.
10
Interleukin-10 Modulation of Virus Clearance and Disease in Mice with Alphaviral Encephalomyelitis.
J Virol. 2018 Feb 26;92(6). doi: 10.1128/JVI.01517-17. Print 2018 Mar 15.
本文引用的文献
1
Induction and molecular signature of pathogenic TH17 cells.
Nat Immunol. 2012 Oct;13(10):991-9. doi: 10.1038/ni.2416. Epub 2012 Sep 9.
2
Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
Am J Pathol. 2012 Jul;181(1):8-18. doi: 10.1016/j.ajpath.2012.03.044. Epub 2012 May 26.
3
Regulation of TH17 cell differentiation by innate immune signals.
Cell Mol Immunol. 2012 Jul;9(4):287-95. doi: 10.1038/cmi.2012.10. Epub 2012 Apr 16.
4
Control of TH17 cells occurs in the small intestine.
Nature. 2011 Jul 17;475(7357):514-8. doi: 10.1038/nature10228.
5
Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4.
J Allergy Clin Immunol. 2010 Jan;125(1):222-30.e1-4. doi: 10.1016/j.jaci.2009.10.012.
6
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells.
J Exp Med. 2009 Jul 6;206(7):1549-64. doi: 10.1084/jem.20082584. Epub 2009 Jun 22.
7
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
Nature. 2006 May 11;441(7090):235-8. doi: 10.1038/nature04753. Epub 2006 Apr 30.
Zotero 插件